Literature DB >> 12829794

Human topoisomerase I promotes HIV-1 proviral DNA synthesis: implications for the species specificity and cellular tropism of HIV-1 infection.

Yuko Shoya1, Kenzo Tokunaga, Hirofumi Sawa, Masae Maeda, Tomonori Ueno, Tomoki Yoshikawa, Hideki Hasegawa, Tetsutaro Sata, Takeshi Kurata, William W Hall, Bryan R Cullen, Hidehiro Takahashi.   

Abstract

Although HIV type 1 (HIV-1) cannot efficiently replicate in simian cells, the mechanism(s) involved in the restriction of virus tropism remain unclear. To investigate this, we have focused on the identification of human cellular factors that can influence the infectivity of HIV-1 derived from African green monkey producer cells. Whereas the infectivity of HIV-1 derived from such cells was only 10-15% of that of human cell-derived virus, expression of human topoisomerase I in the African green monkey cells resulted in a 5-fold increase of the infectivity of progeny HIV-1 virions. Replacement of glutamate-236 and asparagine-237 of human topoisomerase I with the corresponding residues (aspartate and serine, respectively) of the African green monkey enzyme abolished this enhancement of HIV-1 infectivity. This positive effect of human topoisomerase I expression in the African green monkey producer cells seemed to result from the promotion of HIV-1 cDNA synthesis. Thus, human topoisomerase I plays an important role in HIV-1 replication and infectivity, and differences in the species specificity of HIV-1 infection can at least in part be attributed to differences in topoisomerase I activities.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12829794      PMCID: PMC166248          DOI: 10.1073/pnas.1430827100

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  37 in total

1.  Production of high-titer helper-free retroviruses by transient transfection.

Authors:  W S Pear; G P Nolan; M L Scott; D Baltimore
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-15       Impact factor: 11.205

2.  An infectious DNA clone of HIV type 1 subtype C.

Authors:  N Mochizuki; N Otsuka; K Matsuo; T Shiino; A Kojima; T Kurata; K Sakai; N Yamamoto; S Isomura; T N Dhole; Y Takebe; M Matsuda; M Tatsumi
Journal:  AIDS Res Hum Retroviruses       Date:  1999-09-20       Impact factor: 2.205

3.  Cellular topoisomerase I activity associated with HIV-1.

Authors:  D Jardine; G Tachedjian; S Locarnini; C Birch
Journal:  AIDS Res Hum Retroviruses       Date:  1993-12       Impact factor: 2.205

4.  Infection of Macaca nemestrina by human immunodeficiency virus type-1.

Authors:  M B Agy; L R Frumkin; L Corey; R W Coombs; S M Wolinsky; J Koehler; W R Morton; M G Katze
Journal:  Science       Date:  1992-07-03       Impact factor: 47.728

5.  Molecular cloning of a cDNA of a camptothecin-resistant human DNA topoisomerase I and identification of mutation sites.

Authors:  H Tamura; C Kohchi; R Yamada; T Ikeda; O Koiwai; E Patterson; J D Keene; K Okada; E Kjeldsen; K Nishikawa
Journal:  Nucleic Acids Res       Date:  1991-01-11       Impact factor: 16.971

6.  Cyclophilin A is required for an early step in the life cycle of human immunodeficiency virus type 1 before the initiation of reverse transcription.

Authors:  D Braaten; E K Franke; J Luban
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

7.  Effects of the tat and nef gene products of human immunodeficiency virus type 1 (HIV-1) on transcription controlled by the HIV-1 long terminal repeat and on cell growth in macrophages.

Authors:  K M Murphy; M J Sweet; I L Ross; D A Hume
Journal:  J Virol       Date:  1993-12       Impact factor: 5.103

8.  Role of the gag and pol genes of human immunodeficiency virus in the morphogenesis and maturation of retrovirus-like particles expressed by recombinant vaccinia virus: an ultrastructural study.

Authors:  N Hoshikawa; A Kojima; A Yasuda; E Takayashiki; S Masuko; J Chiba; T Sata; T Kurata
Journal:  J Gen Virol       Date:  1991-10       Impact factor: 3.891

9.  Human immunodeficiency virus type 1 reverse transcriptase: enhancement of activity by interaction with cellular topoisomerase I.

Authors:  H Takahashi; M Matsuda; A Kojima; T Sata; T Andoh; T Kurata; K Nagashima; W W Hall
Journal:  Proc Natl Acad Sci U S A       Date:  1995-06-06       Impact factor: 11.205

10.  Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes.

Authors:  R I Connor; B K Chen; S Choe; N R Landau
Journal:  Virology       Date:  1995-02-01       Impact factor: 3.616

View more
  5 in total

1.  Reverse Transcriptase and Cellular Factors: Regulators of HIV-1 Reverse Transcription.

Authors:  Kylie Warren; David Warrilow; Luke Meredith; David Harrich
Journal:  Viruses       Date:  2009-11-10       Impact factor: 5.048

2.  Activity of the human immunodeficiency virus type 1 cell cycle-dependent internal ribosomal entry site is modulated by IRES trans-acting factors.

Authors:  Maricarmen Vallejos; Jules Deforges; Terra-Dawn M Plank; Alejandro Letelier; Pablo Ramdohr; Christopher G Abraham; Fernando Valiente-Echeverría; Jeffrey S Kieft; Bruno Sargueil; Marcelo López-Lastra
Journal:  Nucleic Acids Res       Date:  2011-04-10       Impact factor: 16.971

3.  Human TOP1 residues implicated in species specificity of HIV-1 infection are required for interaction with BTBD2, and RNAi of BTBD2 in old world monkey and human cells increases permissiveness to HIV-1 infection.

Authors:  Bharat Khurana; Lei Zhuang; Prasun K Moitra; Tzanko S Stantchev; Christopher C Broder; Mary Lou Cutler; Peter D'Arpa
Journal:  Virol J       Date:  2010-11-20       Impact factor: 4.099

4.  Differentiation into an Effector Memory Phenotype Potentiates HIV-1 Latency Reversal in CD4+ T Cells.

Authors:  Deanna A Kulpa; Aarthi Talla; Jessica H Brehm; Susan Pereira Ribeiro; Sally Yuan; Anne-Gaelle Bebin-Blackwell; Michael Miller; Richard Barnard; Steven G Deeks; Daria Hazuda; Nicolas Chomont; Rafick-Pierre Sékaly
Journal:  J Virol       Date:  2019-11-26       Impact factor: 5.103

5.  Coregulation of HIV-1 dependency factors in individuals heterozygous to the CCR5-delta32 deletion.

Authors:  Gero Hütter; Christian Blüthgen; Martin Neumann; Mark Reinwald; Daniel Nowak; Harald Klüter
Journal:  AIDS Res Ther       Date:  2013-11-18       Impact factor: 2.250

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.